| scholarly article | Q13442814 |
| P2093 | author name string | Avaniyapuram Kannan Murugan | |
| Ali S Alzahrani | |||
| Arasambattu Kannan Munirajan | |||
| P2860 | cites work | miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 |
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers | Q24650925 | ||
| A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk | Q24655762 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans | Q27861103 | ||
| Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation | Q28236026 | ||
| Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics | Q38931476 | ||
| Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells | Q39186516 | ||
| miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. | Q39227433 | ||
| Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. | Q39234760 | ||
| KRAS alleles: the LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel | Q39424345 | ||
| MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol | Q39455039 | ||
| miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras | Q39618810 | ||
| Upregulation of miR-21 by Ras in vivo and its role in tumor growth. | Q39642600 | ||
| The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS | Q39673083 | ||
| miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer | Q39683202 | ||
| Detection of two novel mutations and relatively high incidence of H-RAS mutations in Vietnamese oral cancer | Q39821517 | ||
| Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma | Q44695573 | ||
| Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck | Q46306270 | ||
| MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. | Q52582850 | ||
| Role of miR-143 targeting KRAS in colorectal tumorigenesis. | Q52591361 | ||
| Malignant neoplasms in Saudi Arabia | Q52858829 | ||
| A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH. | Q53188127 | ||
| miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. | Q53278601 | ||
| RAS oncogenes: the first 30 years. | Q55036584 | ||
| Epidemiology of Oral Cancer in Asia in the Past Decade- An Update (2000-2012) | Q56019542 | ||
| Cancer: The Ras renaissance | Q59058462 | ||
| let-7 microRNA functions as a potential growth suppressor in human colon cancer cells | Q28237683 | ||
| Identification of hundreds of conserved and nonconserved human microRNAs | Q28257480 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras | Q28267417 | ||
| A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation | Q28280072 | ||
| A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy | Q28287088 | ||
| hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells | Q28291188 | ||
| miR-15a and miR-16-1 down-regulation in pituitary adenomas | Q28302259 | ||
| Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway | Q28587965 | ||
| Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 | Q29614651 | ||
| The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
| Ras, PI(3)K and mTOR signalling controls tumour cell growth | Q29614734 | ||
| Ras oncogenes: split personalities | Q29615405 | ||
| Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 | Q29615661 | ||
| MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing | Q29619773 | ||
| Genetic variation in microRNA networks: the implications for cancer research | Q34177121 | ||
| Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. | Q34271727 | ||
| Oral cancer: Current role of radiotherapy and chemotherapy. | Q34647980 | ||
| Polymorphisms in microRNA targets: a gold mine for molecular epidemiology | Q34778438 | ||
| Drugging the undruggable RAS: Mission possible? | Q35163434 | ||
| Human polymorphism at microRNAs and microRNA target sites | Q35652513 | ||
| MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. | Q36012772 | ||
| Oncogenic PI3K deregulates transcription and translation | Q36337966 | ||
| A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis | Q36369415 | ||
| ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma | Q36645822 | ||
| Advances in the biology of oral cancer | Q36720249 | ||
| MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). | Q36725131 | ||
| A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck | Q37093140 | ||
| Genetic polymorphisms and head and neck cancer outcomes: a review | Q37113137 | ||
| Dysregulated molecular networks in head and neck carcinogenesis | Q37274623 | ||
| Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics | Q37577068 | ||
| The molecular biology of head and neck cancer | Q37821229 | ||
| Ras oncogenes in oral cancer: the past 20 years | Q37975342 | ||
| Genetic deregulation of the PIK3CA oncogene in oral cancer | Q38099939 | ||
| MicroRNAs in cancer therapeutic response: Friend and foe | Q38258754 | ||
| miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma | Q38320511 | ||
| P433 | issue | 7 | |
| P921 | main subject | microRNA | Q310899 |
| lip and oral cavity carcinoma | Q55790434 | ||
| P304 | page(s) | 1424-1431 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer | |
| P478 | volume | 231 |
| Q42120428 | MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma |
| Q57181868 | MicroRNA-transcription factor network analysis reveals miRNAs cooperatively suppress RORA in oral squamous cell carcinoma |
| Q47664260 | MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer |
| Q28074691 | Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma |
| Q96348718 | miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A |
| Q92015540 | miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
Search more.